| Vol. 5.23 – 25 June, 2021 |
| |
|
|
| Researchers identified that increased expression of the Notch ligand Jagged1 tracked with Notch activation and nonalcoholic fatty liver disease activity score in human liver biopsy specimens and mouse NASH models. [Science Translational Medicine] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists used a temporally restricted model of hepatic repair in which large-scale hepatocyte injury and regeneration were initiated through the acute loss of Mdm2 in hepatocytes, resulting in the rapid, coordinated proliferation of biliary epithelial cells. [Science Signaling] |
|
|
|
| Investigators showed that clinical-stage orally administered drugs that antagonized the function of cellular inhibitor of apoptosis proteins can eliminate HBV replication and episomal HBV genome in the liver. [Cell Death & Disease] |
|
|
|
| The authors showed that monocyte/macrophage CD11B mRNA levels were increased significantly in livers of biliary atresia patients and positively correlated with the progression of liver inflammation and fibrosis. [Cell Death & Disease] |
|
|
|
| Researchers found that hepatocytes from a mammalian hibernator, the Syrian hamster, exhibited remarkable resistance to prolonged cold culture, whereas murine hepatocytes underwent cold-induced cell death that fulfilled the hallmarks of ferroptosis. [Communications Biology] |
|
|
|
| Few syngeneic mouse models of liver cancer are available. Scientists established liver tumor cell lines from hepatitis C virus transgenic mice fed an atherogenic high-fat diet. [Scientific Reports] |
|
|
|
| Investigators evaluated the effects of L-carnitine supplementation on mitochondrial damage and other hepatocyte injuries following severe burns and the related mechanisms. [Nutrition & Metabolism] |
|
|
|
| Scientists screened stem cells in primary liver cancer cells, analyzed their biological characteristics and proposed the possibility that liver cancer originated from stem cells. [Clinical & Translational Oncology] |
|
|
|
| Immunostaining was performed using liver sections of Caroli disease and polycystic liver disease, and the results were compared with those of congenital hepatic fibrosis and von Meyenburg complex. [Pathology International] |
| |
|
|
|
| The authors describe how functional screens can help to deepen our understanding of liver cancer and guide the development of new therapeutic strategies. [Nature Reviews Gastroenterology & Hepatology] |
|
|
|
| Scientists review the combination of lenvatinib plus pembrolizumab for the treatment of advanced hepatocellular carcinoma. [Expert Opinion On Investigational Drugs] |
|
|
|
|
| Dicerna Pharmaceuticals, Inc. announced it has initiated patient dosing in the Company’s Phase II ESTRELLA trial of belcesiran, an investigational GalXC™ RNAi therapeutic candidate for the treatment of alpha-1 antitrypsin deficiency-associated liver disease. [Dicerna Pharmaceuticals, Inc.] |
|
|
|
| Terns Pharmaceuticals, Inc. announced the initiation of patient dosing in the AVIATION Trial, a Phase Ib clinical trial evaluating TERN-201, an orally-administered, highly selective inhibitor of vascular adhesion protein-1 (VAP-1) in patients with non-alcoholic steatohepatitis. [Terns Pharmaceuticals, Inc.] |
|
|
|
|
| November 29 – December 1, 2021 Barcelona, Spain |
|
|
|
|
|
| University of Southern Denmark – Odense, Denmark |
|
|
|
| Massachusetts General Hospital – Boston, Massachusetts, United States |
|
|
|
| German Research Center for Environmental Health – Neuherberg, Germany |
|
|
|
| University of Pittsburgh – Pittsburgh, Pennsylvania, United States |
|
|
|
| Gilead Sciences, Inc. – Foster City, California, United States |
|
|
|
|